18 Jan 2022 , 01:56 PM
Lupin Ltd.’s share gained over 1% after its announcement to acquire a portfolio of Brands of Anglo-French Drugs & Industries & associates, to strengthen its portfolio in vitamins, supplements, and minerals.
The portfolio of products that is being acquired falls within the business line of the company and will enable the addition of established brands with high recall amongst healthcare professionals, especially in the Minerals, Vitamins, and supplements category.
This will create new value for the company and would lead to EBITDA margin accretion, the company said in the filing.
The acquisition will be completed by March 2022. Company is paying a consideration of about Rs 325 crores including working capital amounting to Rs 9 crores, partly on cash and debt basis.
To be precise, the acquisition is only of a portfolio of products and not any unit or division of the company.
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
